Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine.

Loftis, Jennifer M; Ramani, Sankrith; Firsick, Evan J; Hudson, Rebekah; Le-Cook, Anh; Murnane, Kevin S; Vandenbark, Arthur; Shirley, Renee L

Loftis, Jennifer M; Ramani, Sankrith; Firsick, Evan J; Hudson, Rebekah; Le-Cook, Anh; Murnane, Kevin S; Vandenbark, Arthur; Shirley, Renee L.

Afiliação

Loftis JM; Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.
Ramani S; Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States.
Firsick EJ; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.
Hudson R; Methamphetamine Research Center, Oregon Health & Science University, Portland, OR, United States.
Le-Cook A; Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.
Murnane KS; Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.
Vandenbark A; Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.
Shirley RL; Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.

Front Psychiatry ; 14: 1259041, 2023.

Article em En | MEDLINE | ID: mdl-38025429

Palavras-chave

MIP-2; addiction; chemokine; drug discovery; frontal cortex; inflammation; methamphetamine; psychostimulant

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Psychiatry Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google